Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.
The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this stud...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5066968?pdf=render |
id |
doaj-91cf519af2f146498a3945b5c9dc7aec |
---|---|
record_format |
Article |
spelling |
doaj-91cf519af2f146498a3945b5c9dc7aec2020-11-25T00:08:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016461710.1371/journal.pone.0164617Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.Alexander U BrandtElena Meinert-BohnJan Leo RinnenthalHanna ZimmermannJanine MikolajczakTimm OberwahrenbrockSebastian PapazoglouCaspar F PfüllerJohann SchinzelBjörn TackenbergFriedemann PaulKatrin HahnJudith Bellmann-StroblThe PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this study was to identify potential structural and functional alterations in the afferent visual system in HNPP patients.Twenty HNPP patients and 18 matched healthy controls (HC) were recruited in a cross-sectional study. Participants underwent neurological examination including visual acuity, visual evoked potential (VEP) examination, optical coherence tomography (OCT), and magnetic resonance imaging with calculation of brain atrophy, regarding grey and white matter, and voxel based morphometry (VBM), in addition answered the National Eye Institute's 39-item Visual Functioning Questionnaire (NEI-VFQ). Thirteen patients and 6 HC were additionally examined with magnetic resonance spectroscopy (MRS).All patients had normal visual acuity, but reported reduced peripheral vision in comparison to HC in the NEI-VFQ (p = 0.036). VEP latency was prolonged in patients (P100 = 103.7±5.7 ms) in comparison to healthy subjects (P100 = 99.7±4.2 ms, p = 0.007). In OCT, peripapillary retinal nerve fiber layer thickness RNFL was decreased in the nasal sector (90.0±15.5 vs. 101.8±16.5, p = 0.013), and lower nasal sector RNFL correlated with prolonged VEP latency (Rho = -0.405, p = 0.012). MRS revealed reduced tNAA (731.4±45.4 vs. 814.9±62.1, p = 0.017) and tCr (373.8±22.2 vs. 418.7±31.1, p = 0.002) in the visual cortex in patients vs. HC. Whole brain volume, grey and white matter volume, VBM and metabolites in a MRS sensory cortex control voxel did not differ significantly between patients and HC.PMP22 deletion leads to functional, metabolic and macro-structural alterations in the afferent visual system of HNPP patients. Our data suggest a functional relevance of these changes for peripheral vision, which warrants further investigation and confirmation.http://europepmc.org/articles/PMC5066968?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexander U Brandt Elena Meinert-Bohn Jan Leo Rinnenthal Hanna Zimmermann Janine Mikolajczak Timm Oberwahrenbrock Sebastian Papazoglou Caspar F Pfüller Johann Schinzel Björn Tackenberg Friedemann Paul Katrin Hahn Judith Bellmann-Strobl |
spellingShingle |
Alexander U Brandt Elena Meinert-Bohn Jan Leo Rinnenthal Hanna Zimmermann Janine Mikolajczak Timm Oberwahrenbrock Sebastian Papazoglou Caspar F Pfüller Johann Schinzel Björn Tackenberg Friedemann Paul Katrin Hahn Judith Bellmann-Strobl Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. PLoS ONE |
author_facet |
Alexander U Brandt Elena Meinert-Bohn Jan Leo Rinnenthal Hanna Zimmermann Janine Mikolajczak Timm Oberwahrenbrock Sebastian Papazoglou Caspar F Pfüller Johann Schinzel Björn Tackenberg Friedemann Paul Katrin Hahn Judith Bellmann-Strobl |
author_sort |
Alexander U Brandt |
title |
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. |
title_short |
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. |
title_full |
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. |
title_fullStr |
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. |
title_full_unstemmed |
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. |
title_sort |
afferent visual pathway affection in patients with pmp22 deletion-related hereditary neuropathy with liability to pressure palsies. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this study was to identify potential structural and functional alterations in the afferent visual system in HNPP patients.Twenty HNPP patients and 18 matched healthy controls (HC) were recruited in a cross-sectional study. Participants underwent neurological examination including visual acuity, visual evoked potential (VEP) examination, optical coherence tomography (OCT), and magnetic resonance imaging with calculation of brain atrophy, regarding grey and white matter, and voxel based morphometry (VBM), in addition answered the National Eye Institute's 39-item Visual Functioning Questionnaire (NEI-VFQ). Thirteen patients and 6 HC were additionally examined with magnetic resonance spectroscopy (MRS).All patients had normal visual acuity, but reported reduced peripheral vision in comparison to HC in the NEI-VFQ (p = 0.036). VEP latency was prolonged in patients (P100 = 103.7±5.7 ms) in comparison to healthy subjects (P100 = 99.7±4.2 ms, p = 0.007). In OCT, peripapillary retinal nerve fiber layer thickness RNFL was decreased in the nasal sector (90.0±15.5 vs. 101.8±16.5, p = 0.013), and lower nasal sector RNFL correlated with prolonged VEP latency (Rho = -0.405, p = 0.012). MRS revealed reduced tNAA (731.4±45.4 vs. 814.9±62.1, p = 0.017) and tCr (373.8±22.2 vs. 418.7±31.1, p = 0.002) in the visual cortex in patients vs. HC. Whole brain volume, grey and white matter volume, VBM and metabolites in a MRS sensory cortex control voxel did not differ significantly between patients and HC.PMP22 deletion leads to functional, metabolic and macro-structural alterations in the afferent visual system of HNPP patients. Our data suggest a functional relevance of these changes for peripheral vision, which warrants further investigation and confirmation. |
url |
http://europepmc.org/articles/PMC5066968?pdf=render |
work_keys_str_mv |
AT alexanderubrandt afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT elenameinertbohn afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT janleorinnenthal afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT hannazimmermann afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT janinemikolajczak afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT timmoberwahrenbrock afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT sebastianpapazoglou afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT casparfpfuller afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT johannschinzel afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT bjorntackenberg afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT friedemannpaul afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT katrinhahn afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT judithbellmannstrobl afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies |
_version_ |
1725415398645432320 |